新型多抗原ORF病毒衍生疫苗引发了单价和双价格的SARS-CoV-2防护反应
Dominique Julien Burri1, Louis Renz1, Melanie Mueller2
1Speransa Therapeutics, Frankfurt am Main, 60327 Frankfurt, Germany.
Vaccines
|May 25, 2024
概括
基于Orf病毒 (ORFV) 的COVID-19疫苗Prime-2-CoV_Beta在临床前研究中显示出强大的免疫反应. 它在不同策略中表现出可比的免疫性和对SARS-CoV-2感染的保护.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- SARS-CoV-2 变种的出现需要更新的疫苗策略.
- 对疫苗和感染的现有免疫力会影响新候选药物的有效性.
- 奥尔夫病毒 (ORFV) 为疫苗开发提供了一个新的平台.
研究的目的:
- 评估Prime-2-CoV_Beta对SARS-CoV-2的免疫性和保护功效.
- 在预免疫动物模型中评估对Prime-2-CoV_Beta的反应.
- 为了比较单价和双价Prime-2-CoV疫苗策略.
主要方法:
- 在预免疫小鼠中量化幽默和细胞免疫反应.
- 评估单和双价Prime-2-CoV候选物对子的保护功效.
- 使用基于ORF病毒 (ORFV) 的疫苗,表达SARS-CoV-2核和尖端蛋白.
主要成果:
- 普莱姆-2-CoV_Beta诱导了天真动物强烈的幽默和细胞免疫力.
- 在短时间间隔使用Prime-2-CoV_Beta重复增强并没有显著增加抗体标位.
- 单和双价Prime-2-CoV免疫策略显示出类似的免疫性和保护性.
结论:
- 奥尔夫病毒 (ORFV) 显示出作为SARS-CoV-2疫苗平台的希望.
- 普莱姆-2-CoV_Beta证明了COVID-19疫苗开发的潜力.
- 需要进一步的研究来探索该平台对不断演变的变种的有效性.
更多相关视频
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.6K
相关概念视频
Cross-reactivity
28.8K
Overview
28.8K
Vaccinations
44.3K
Overview
44.3K
Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccine Production
152
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
152
Vaccines
104
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
104
